Fernando Rivero-Crespo
5 Papers
81 Citations
Fernando Rivero-Crespo is an academic researcher. The author has contributed to research in topics: Acute coronary syndrome & Myocardial infarction. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
A prospective randomised comparison of titanium-nitride- oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial
Pasi P. Karjalainen,Matti Niemelä,Juhani Airaksinen,Fernando Rivero-Crespo,Hannu Romppanen,Jussi Sia,Jacques Lalmand,Bernard De Bruyne,Adam Debelder,Marc Carlier,Wail Nammas,Antti Ylitalo,Otto M. Hess,Bace-Acs study investigators +13 more
TL;DR: In patients presenting with ACS, BAS achieved a clinical outcome that was non-inferior to EES at 12-month follow-up, and the safety and efficacy of BAS versus everolimus-eluting stents (EES) in patients with acute coronary syndrome was compared.
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial
Pasi P. Karjalainen,Wail Nammas,Antti Ylitalo,Bernard De Bruyne,Jacques Lalmand,Adam de Belder,Fernando Rivero-Crespo,Kari Kervinen,Juhani Airaksinen +8 more
TL;DR: In the current final report of the randomized BASE ACS trial in patients with ACS, BAS implantation was associated with a rate of cumulative MACE at long-term follow-up that was statistically non-inferior to EES.
26
Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial
Hannu Romppanen,Wail Nammas,Kari Kervinen,Juhani Airaksinen,Mikko Pietilä,Fernando Rivero-Crespo,Adam Debelder,Pintoko Tedjokusumo,Jussi Mikkelsson,Antti Ylitalo,Pasi P. Karjalainen +10 more
TL;DR: In patients presenting with ACS, the rates of both stent-oriented and patient-oriented outcomes at 24-month follow-up in the BAS group were similar to those in the EES group.
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
Pasi P. Karjalainen,Matti Niemelä,Mikko Pietilä,Jussi Sia,Adam de Belder,Fernando Rivero-Crespo,Bernard De Bruyne,Wail Nammas +7 more
TL;DR: In patients presenting with ACS, BAS was associated with a clinical outcome non-inferior to EES at 4-year follow-up, and independent predictors of MACE were calcified lesions, the number of vessels treated, and reference vessel diameter.
11
Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial
Pasi P. Karjalainen,Wail Nammas,Kari Kervinen,Adam de Belder,Fernando Rivero-Crespo,Antti Ylitalo,Juhani Airaksinen +6 more
TL;DR: Patients presenting with acute coronary syndrome who were treated for calcified lesions had worse long-term clinical outcome, compared with those treated for non-calcified lesions, mainly due to more frequent safety events.
5